Follow on Google News News By Tag * Hepatitis * Cases * Epidemiologic * Prevalent * Disease * Vaccination * 50-59 * Criteria * Setting * 40-49 * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | "Epidemiology: Hepatitis B in China" is now available at Fast Market ResearchNew Pharmaceuticals market report from Datamonitor: "Epidemiology: Hepatitis B in China"
Even with the projected overall decrease during the forecast period, the prevalence of hepatitis B will continue to remain at the intermediate endemicity level. China will have an estimated 63.06 million prevalent cases of hepatitis B in 2020. Features and benefits * Gain insight into market potential, including a robust, 10-year epidemiology forecast of hepatitis B prevalent cases. * Understand the key epidemiologic risk factors associated with hepatitis B in China. Highlights Datamonitor estimates that the prevalence of hepatitis B in China is highest among adults aged 40-49 years and also 50-59 years; both age groups are projected to have an increase in the number of prevalent cases during the forecast period, according to Datamonitor forecasts. The increase in the two oldest groups (40-49 and 50-59) is directly related to the projected population growth in these age groups. The two age groups will remain unaffected by the change in vaccination policy during the forecast period. Your key questions answered * What are the most robust sources for hepatitis B prevalence data? * How will patient the population change over the next decade in China? * How do changes in population structure and risk factors affect the trend in prevalent hepatitis B cases? For more information or to purchase this report, go to: - http://www.fastmr.com/ Report Table of Contents: Executive Summary OVERVIEW Catalyst Summary DISEASE DEFINITION AND DIAGNOSIS CRITERIA Modes of transmission Vaccinations Diagnosis Criteria TEMPORAL TRENDS Changing vaccination policy Changing disease prevalence Changing transmission patterns RISK FACTORS Unsafe medical practices Blood transfusions Unsafe injection practices Rural and urban residential setting CO-MORBIDITIES Concurrent Human Immunodeficiency Virus infection EPIDEMIOLOGIC FORECASTING Sources of epidemiologic data Description of methods EPIDEMIOLOGIC RESULTS Current prevalent cases and future trends By age group By urban/rural setting Average annual growth rate of disease population DISCUSSION Strengths of our epidemiologic projections BIBLIOGRAPHY Journal articles Websites Datamonitor Reports APPENDIX Module methodology About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|